Advancing the Science

Mayo Clinic Medical Science Blog

Items Tagged ‘atrial fibrillation’

June 19th, 2017

1 in 6 taking blood-thinning drugs may not be getting right dose, research shows

By Adam Harringa harringaadam

A growing number of Americans are expected to develop atrial fibrillation, a common heart condition characterized by an irregular and rapid heart rate. But almost 1 in 6 of the millions of Americans on new blood-thinning medications for a-fib may not be getting the right dose, Mayo Clinic research finds.

View full entry

Tags: anticoagulant, apixaban, atrial fibrillation, blood-thinner, dabigatran, Dr. Peter Noseworthy, Dr. Xiaoxi Yao, Kern Center, kidney disease, Mayo Clinic research, medical research, OptumLabs


May 3rd, 2016

OLD DRUG OR NEW?

By Elizabeth Zimmermann Young elizabethzimmermann

Determining which drug works better for which patients “Our findings definitely point toward important age-related risk that merits consideration when doctors are making treatment recommendations,” says lead author Neena S. Abraham, M.D. To the average TV viewer, it may seem like new drugs flood the marketplace daily.However, from the 1950s until just recently, warfarin was […]

View full entry

Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, dabigatran, Kern Center, medical research, Neena Abraham, rivaroxaban, warfarin


January 5th, 2016

Did your patient have cardiac ablation? Don’t stop the anticoagulant!

By Elizabeth Zimmermann Young elizabethzimmermann

Peter Noseworthy, M.D., is a cardiac electrophysiologist at Mayo Clinic, and a Kern Health Care Delivery Scholar in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. ________________________________________________________________________ As a cardiac electrophysiologist, I am interested in helping to improve health and quality of life for my patients […]

View full entry

Tags: anticoagulant, atrial fibrillation, Optum Labs, OptumLabs, Peter Noseworthy, stroke


Contact Us · Privacy Policy